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Background. The present study aimed to evaluate a potential eﬀect of ERAS on surgical site infections (SSI). Methods. Colonic
surgical patients operated between May 2011 and September 2015 constituted the cohort for this retrospective analysis. Over
100 items related to demographics, surgical details, compliance, and outcome were retrieved from a prospectively maintained
database. SSI were traced by an independent National surveillance program. Risk factors for SSI were identiﬁed by univariate
and multinomial logistic regression. Results. Fifty-four out of 397 patients (14%) developed SSI. Independent risk factors
for SSI were emergency surgery (OR 1.56; 95% CI 1.09–1.78, p = 0 026), previous abdominal surgery (OR 1.7; 95% CI 1.32–1.87,
p = 0 004), smoking (OR 1.71; 95% CI 1.22–1.89, p = 0 014), and oral bowel preparation (OR 1.86; 95% CI 1.34–1.97, p = 0 013),
while minimally invasive surgery (OR 0.3; 95% CI 0.16–0.56, p < 0 001) protected against SSI. Compliance to ERAS items of
>70% was not retained as a protective factor for SSI after multivariate analysis (OR 0.94; 95% CI 0.46–1.92, p = 0 86).
Conclusions. Smoking, open and emergency surgery, and bowel preparation were risk factors for SSI. ERAS pathway had
no independent impact while minimally invasive approach did. This study was registered under ResearchRegistry.com
(UIN researchregistry2614).
1. Introduction
Enhanced recovery after surgery (ERAS) pathways aim
to reduce surgical stress [1]. In colorectal surgery, ERAS
has been associated with decreased complication rates,
positively inﬂuencing length of stay and costs [2, 3].
Thus, ERAS represents a fundamental shift in periopera-
tive care.
Surgical site infections (SSI) occur in up to 22% of
patients and depend on patient- and surgery-related factors
[4]. In Switzerland, SSI rate of 18.2% after colectomy has
been described recently in a large prospective surveillance
study [5].
SSI increase hospital readmission rates [6, 7] and health
costs [8] and delay adjuvant chemotherapy [9]. Appropriate
choice and timing of antibiotic prophylaxis, normothermia,
and perioperative normoglycemia have been identiﬁed as pro-
tective factors against SSI [10, 11]. Several implementation
programs for evidence-based practice have demonstrated a
decrease of SSI applying these principles in colorectal surgery
[12, 13], and these items are part of ERAS guidelines for colo-
rectal surgery [3].
The aim of the present study was to assess incidence and
risk factors for SSI in a cohort of colonic surgery patients
treated within an ERAS pathway.
2. Methods
2.1. Patients. All consecutively operated colonic surgical
patients between May 2011 and September 2015 at the
Lausanne University Hospital (CHUV) were included in
the analysis. All patients were treated within a standardized
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ERAS pathway [14]. Open and laparoscopic colectomies in
an elective or emergency (since April 2012) setting were
included. The only exclusion criterium was documented
anastomotic leakage in order to avoid confounding factor
for SSI.
This study was approved by the Institutional Review
Board (Commission cantonale d’éthique de la recherche sur
l’être humain CER-VD, # 2016–00991). The study was
conducted according to the STROBE criteria and registered
under ResearchRegistry.com (UIN researchregistry2614).
Demographic and surgical information was prospectively
assessed in a dedicated database by the specialized ERAS
nurse; accuracy of data entry was cross-checked by indepen-
dent review during Hebdomadal audits. Data about ERAS-
speciﬁc perioperative care items were prospectively recorded
[3]. Demographic information included age, gender, body
mass index (BMI), American Society of Anesthesiologists
(ASA) score, and smoking status (daily smoker versus non-
smoker) at the time of the procedure. Further recorded vari-
ables were diagnoses including the presence of malignancy,
immunosuppressive treatments (i.e., steroids) by the time of
the procedure, neoadjuvant chemotherapy, drug-requiring
diabetes mellitus, and previous abdominal surgery. Surgical
information included type of procedure (sigmoid, left, right,
or total colectomy (excluding proctocolectomy) and Hart-
mann reversal), approach (open versus laparoscopy with
conversion assigned to laparoscopy according to the inten-
tion-to-treat principle), setting (elective versus emergency
within 72 hours after unplanned admission), duration, anas-
tomotic technique (hand-sewn, circular, or linear stapler),
and confection of a new stoma (both colo- or ileostomy).
According to the Institutional guidelines, intravenous cefur-
oxime 1.5 g and metronidazole 500mg were systematically
administered 60–30min before incision. As an alternative
in case of nontolerance, clindamycin 600mg and ciproﬂoxa-
cin 400mg were used. Compliance to cefuroxime administra-
tion and timing of administration were analyzed.
2.2. Assessment of Compliance to ERAS Items. Overall compli-
ance to 19 pre-, peri-, and postoperative ERAS care items
was assessed and stratiﬁed with a cutoﬀ of 70% according
to the previous publications [15, 16]. These items were
preadmission patient education, no oral bowel preparation,
preoperative oral carbohydrate drinks, no preoperative long-
acting sedative medication, thromboprophylaxis, antibiotic
prophylaxis, postoperative nausea and vomiting (PONV)
prophylaxis (droperidol 1mg, ondansetron 4mg, and betha-
methasone 4mg), intraoperative thoracic epidural analgesia,
hypothermia prevention (active warming by air blanket),
ﬂuid administration guidance, balanced intravenous ﬂuids
(ml/kg/h< 7), no prophylactic nasogastric tube, no abdominal
drain, sip feeds at postoperative day (POD) 0 of >300 kcal,
suﬃcient oral ﬂuids (>1L) at POD 0, systematic laxatives, IV
ﬂuid administration at POD 1 of <500mL, weight gain of
<1.5 kg at POD 1, and mobilization at all at POD 0.
2.3. Assessment and Classiﬁcation of Surgical Site Infection.
SSI data were prospectively monitored through an in-
hospital and postdischarge National surveillance program
(systematic phone call at postoperative day (POD) 30) by
an independent committee (http://www.swissnoso.ch).
Methodological details of this assessment have been pub-
lished previously [5]. SSI were classiﬁed according to the
Center for Disease Control (CDC) National Nosocomial
Infection Surveillance (NNIS) criteria into superﬁcial inci-
sional, deep incisional, and organ space infections [17]. Con-
tamination class was assessed by the surgeon and classiﬁed at
the end of the procedure as clean contaminated (grade II),
contaminated (grade III), or infectious (grade IV). A second
independent assessment (NNIS score 0–3) was performed
by the surveillance committee according to NNIS criteria
based on ASA score, wound class (independently assessed
based on surgery reports and stratiﬁed likewise (II–IV)),
and duration of surgery.
2.4. Outcomes/Study Endpoints. The primary endpoint was
the rate of SSI. Uni- and multivariate risk factors for SSI were
identiﬁed among demographic, surgery-related, and periop-
erative ERAS care items. Modiﬁable pre- and perioperative
ERAS items, overall compliance to the ERAS pathway, read-
mission rates, and length of stay were compared between the
two groups (SSI versus no SSI).
2.5. Statistical Analysis. Descriptive statistics for categorical
variables were reported as frequency (%), while continuous
variables were reported as mean (standard deviation) or
median (interquartile range). Chi-square was used for com-
parison of categorical variables. All statistical tests were
two-sided, and a level of 0.05 was used to indicate statistical
signiﬁcance. Variables with p values ≤0.05 including poten-
tial confounding factors (ERAS compliance >70%, smoking
status) were then entered into a multivariate logistic regres-
sion (based on a probit regression model) to provide adjusted
estimations of the odds ratio (OR). Data analysis was per-
formed with the Statistical Software for the Social Sciences
SPSS Advanced Statistics 22 (IBM Software Group, 200W.
Madison St., Chicago, IL; 60606 USA).
3. Results
3.1. Patients. Out of 413 operated patients, 16 (4%) were
excluded due to endoscopically, surgically, or radiologically
proven anastomotic leakage, leaving 397 patients for ﬁnal
analysis. Fifty-four patients (14%) developed SSI. Of these,
21 (39%) presented with incisional SSI, while 33 (61%) were
diagnosed with organ space infection.
Baseline characteristics and diagnoses are displayed in
Table 1. Both groups (SSI versus no SSI) were comparable
except for smoking status (22 versus 18%, p = 0 051) and
previous abdominal surgery (46 versus 30%, p = 0 005).
Surgical details are illustrated in Table 2. Univariate risk
factors for SSI were emergency setting (50 versus 27%,
p < 0 001) and wound class as assessed by the independent
surveillance committee (III-IV: 65 versus 51%, p = 0 015),
while minimally invasive surgery consisted a protective
factor (41 versus 72%, p < 0 001).
3.2. ERAS Compliance and Modiﬁable Pre- and Perioperative
ERAS Items. Two hundred and eight patients (52%)
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presented an overall compliance of at least 70% to ERAS
items. Compliance of >70% was linked to an apparent
decreased SSI rate, which did not reach the limit of signiﬁ-
cance after univariate analysis (41 versus 54%, p = 0 065).
Modiﬁable pre- and perioperative ERAS items are illus-
trated in Figure 1. All items were comparable between
the two groups except for oral bowel preparation (7 versus
1%, p = 0 014).
Cefuroxim/metronidazole administration within one
hour of incision was comparable between the two groups
(63 versus 72%, p = 0 174).
3.3. Independent Risk Factors for SSI. Independent risk fac-
tors for SSI were emergency surgery (OR 1.56; 95% CI
1.09–1.78, p = 0 026), previous abdominal surgery (OR 1.7;
95% CI 1.32–1.87, p = 0 004), smoking (OR 1.71; 95% CI
1.22–1.89, p = 0 014), and oral bowel preparation (OR 1.86;
95% CI 1.34–1.97, p = 0 013), while minimally invasive sur-
gery (OR 0.3; 95% CI 0.16–0.56, p < 0 001) protected against
SSI. Compliance to ERAS items of >70% was not a protective
factor for SSI after multivariate analysis (OR 0.94; 95% CI
0.46–1.92, p = 0 86). Figure 2 gives an overview of indepen-
dent factors associated with SSI.
3.4. Outcome. SSI were associated with longer mean length of
hospital stay (20± 17 versus 7± 6 days, p < 0 001) and higher
readmission rate (24 versus 2%, p < 0 001).
4. Discussion
In the present study of 397 colorectal patients, it was not
possible to demonstrate a beneﬁt of ERAS compliance on
SSI incidence, while minimally invasive surgery was clearly
protective.
Fourteen percent of patients after colectomy presented
with SSI within a 30-day postoperative observation period
by an independent National surveillance committee. Several
risk factors including smoking, emergency surgery, open sur-
gery, and previous abdominal surgery were independently
associated with SSI. According to ERAS guidelines, oral
bowel preparation was not recommended for colonic surgery
and was carried out in only 2% of the present cohort almost
exclusively in the early study period. Interestingly, this was
the only modiﬁable ERAS item independently associated
with an increased SSI rate. Overall compliance to ERAS path-
way of >70% was not linked to a signiﬁcant decrease in SSI
neither in uni- nor in multivariate analysis.
A recent meta-analysis assessed the impact of enhanced
recovery protocols on healthcare-related infections in
patients undergoing abdominal and pelvic surgeries [18].
Interestingly, out of 36 included randomized controlled tri-
als, only one single study observed a beneﬁcial eﬀect of ERAS.
However, meta-analysis of pooled data led to a risk reduction
of 25% comparing ERAS to traditional care. This ﬁnding
joins formerly described beneﬁcial eﬀects of ERAS compared
Table 1: Baseline characteristics.
All patients (n = 397) SSI (n = 54) No SSI (n = 343) p
Age (years) (mean± SD) 64± 16 66± 15 64± 16 0.395
Gender
Male (%) 186 (47) 24 (44) 162 (47) 0.703
BMI (kg/m2)
>25 (%) 212 (53) 31 (57) 181 (53) 0.525
ASA group
I-II (%) 258 (65) 35 (65) 223 (65)
0.977
III-IV (%) 139 (35) 19 (35) 120 (33)
Smoking (%) 75 (19) 12 (22) 63 (18) 0.051
Diabetes (%) 48 (13) 6 (11) 42 (12) 0.765
Immunosuppression (%) 47 (12) 5 (9) 42 (12) 0.528
Neoadjuvant chemotherapy (%) 26 (7) 3 (6) 24 (7) 0.696
Previous abdominal surgery (%) 129 (33) 25 (46) 104 (30) 0.005
Malignancy (%) 210 (53) 35 (65) 175 (51) 0.215
Diagnosis (%)
Primary adenocarcinoma 179 (45) 18 (33) 161 (47) 0.491
Other primary malignancy 7 (2) 1 (2) 6 (2)
Metastatic disease 13 (3) 4 (7) 9 (2)
Benign tumor/polyp 22 (6) 2 (4) 20 (6)
Inﬂammatory bowel disease 26 (6) 5 (9) 21 (6)
Diverticular disease 90 (23) 15 (28) 75 (22)
Functional disorder 28 (7) 4 (7) 24 (7)
Other benign disorder 32 (8) 5 (10) 27 (8)
SSI: surgical site infection; BMI: body mass index; ASA: American Society of Anaesthesiologists. Signiﬁcant values are indicated in bold characters.
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to traditional care. Reduced overall morbidity, length of stay,
and costs have been repeatedly proven as a result of
decreased surgical stress response [2, 14, 19]. In the present
study, all patients without exception were treated within a
standardized ERAS care pathway, including emergency
operations. The aim was thus not to compare SSI rate to
traditional care but to assess SSI rate among diﬀerent compli-
ance groups. Gustafsson has shown that best results were
achieved with the highest overall compliance to ERAS [15].
These results have been conﬁrmed in a recent study suggest-
ing a minimal overall compliance of 70% to achieve
improved postsurgical results [16]. As a consequence, the
present study aimed to compare compliant (>70%) to less
compliant (<70%) patients and to analyze individual compli-
ance to modiﬁable ERAS items. Two reasons might account
for similar SSI rates among compliant and less compliant
patients. First, the modest sample size might be prone to type
II error. Second, ERAS has been shown to decrease above all
nonsurgical, especially cardiopulmonary complications,
rather than surgical complications [2].
In the present cohort, 14% of patients were diagnosed
with either superﬁcial or organ space SSI as deﬁned. This rate
is comparable to former large-scale studies [20–22]. It has to
be emphasized that all patients were systematically followed
by dedicated and independent abstractors limiting artiﬁcially
low infection rates due to detection bias.
Surgical complications and anastomotic leaks are mainly
linked to patient-related factors or caused by technical short-
comings. Therefore, surgical complications were shown not
to be modiﬁed by ERAS pathways [2]. Inevitably, anasto-
motic leaks entail intra-abdominal abscess and frequently
superﬁcial side infection as a consequence. Hence, patients
Table 2: Surgical details.
All patients (n = 397) (%) SSI (n = 54) (%) No SSI (n = 343) (%) p
Procedure
Left colectomy 46 (12) 7 (13) 39 (11)
0.519
Sigmoid resection 140 (35) 17 (32) 123 (36)
Right colectomy 135 (34) 21 (39) 114 (33)
Total colectomy 28 (7) 5 (9) 23 (7)
Hartmann reversal 39 (10) 4 (7) 35 (10)
Other 9 (2) 0 9 (3)
Minimally invasive surgery 270 (68) 22 (41) 248 (72) <0.001
Emergency 118 (30) 27 (50) 91 (27) <0.001
Operating time> 3 hours 186 (47) 28 (52) 158 (46) 0.465
New stoma
No 340 (86) 50 (92) 290 (85)
0.293Ileostomy 28 (7) 2 (4) 26 (7)
Colostomy 29 (7) 2 (4) 27 (8)
Anastomotic technique
Hand-sewn 74 (18) 10 (19) 64 (19)
0.73
Circular staplers 177 (45) 21 (39) 156 (46)
Linear staplers 103 (26) 18 (33) 85 (25)
Other/no anastomosis 43 (11) 5 (9) 38 (8)
Contamination class (assessed by surgeon)
II 351 (88) 50 (92) 301 (88)
0.312
III-IV 46 (12) 4 (8) 42 (12)
Wound class (assessed by surveillance committee)
II 187 (47) 19 (35) 168 (49)
0.015
III-IV 210 (53) 35 (65) 175 (51)
Antibiotic administration
<1 hour before incision 281 (71) 34 (63) 247 (72) 0.174
NNIS score
0 74 (19) 7 (13) 67 (20)
0.059
1 145 (37) 15 (28) 130 (38)
2 138 (35) 22 (41) 116 (34)
3 40 (10) 10 (19) 30 (9)
SSI: surgical site infection; Contamination/wound class: II—clean contaminated, III—contaminated, IV—infectious; NNIS: National Nosocomial Infection
Surveillance. Signiﬁcant values are indicated in bold characters.
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with a proven anastomotic leak were excluded as an over-
whelming confounder for the purpose of the present study.
However, contamination class assessed by the treating
surgeon and independent assessment of perioperative con-
tamination by the surveillance committee (NNIS score,
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Figure 1: Pre- and intraoperative modiﬁable ERAS items. Comparison of compliance to modiﬁable pre- and intraoperative ERAS-related
items among patients with SSI (black bars) and patients without SSI (grey bars). Premedication = administration of long-acting sedative
medication. SSI: surgical site infection; PONV: postoperative nausea and vomiting; EDA: epidural analgesia; NGT: nasogastric tube.
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Figure 2: Independent risk factors for SSI. Odds ratio for outcome SSI, 95% conﬁdence IntervaI.
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signiﬁcance after univariate analysis, wound class did not
correlate with SSI after multivariate analysis. An explanation
might be that both measures rely on subjective assessment,
and hence observer-dependent diﬀerences in individual
grading of contamination might be a consequence. Interest-
ingly, surgeons classiﬁed most procedures (88%) as contam-
ination class II, while half of the procedures were classiﬁed as
grades III-IV by the independent committee. Another
parameter that deserves in-depth discussion is antimicrobial
prophylaxis [23]. In the present cohort, antibiotic prophy-
laxis was delivered in all patients without exception, however
with appropriate timing of administration between 30–
60min before incision in 71% of patients only. Despite a dif-
ference of almost 10% among the two groups (63 versus
72%), this result was not signiﬁcant, possibly due to type II
error. While timing of antibiotic administration is crucial,
mode of administration is debated [24]. While a combined
oral and IV administration has been most beneﬁcial in a for-
mer study [25], no superiority of this combination was
observed in a more recent randomized trial [26]. Due to an
inherent risk of dehydration, distress and postoperative ileus,
mechanical bowel preparation is not recommended by ERAS
guidelines [3], in line with a comprehensive Cochrane review
of almost 6000 patients [27], and should remain an excep-
tion, that is, when intraoperative colonoscopy is needed.
Whether oral antibiotics need to be combined with mechan-
ical bowel preparation is a matter of debate [24]. Recent
evidence suggested this combination [28–30] as a way to
reduce SSI, in contrast to the results of former randomized
studies [31]. To draw ﬁnal conclusions, results of ongoing
randomized trials (i.e., MOBILE trial, NCT02652637) are
eagerly awaited before the next revision of enhanced recovery
guidelines for colorectal surgery.
In a large quality improvement project including more
than 27000 patients who underwent colonic surgery, open
approach and active smoking were independent risk factors
for both superﬁcial and deep/organ space infection [32], sim-
ilar to the results of the present study. It is therefore important
to insist during the outpatient visit on smoking cessation prior
to surgery. Minimally invasive colonic surgery was associated
with a lower rate of SSI in several studies [33, 34]. Moreover,
the combination of laparoscopy and ERAS might be even
more beneﬁcial [35–37]. Several known risk factors for SSI,
including diabetes and hypothermia, were not retained in
the present study [38, 39], probably reﬂecting beneﬁts of the
ERAS protocol including stringent carbohydrate homeostasis
and high compliance to hypothermia prevention.
Some limitations of the present study beyond its retro-
spective nature need to be discussed. Due to modest sample
size, the study is prone to type II error. Some of the analyzed
items (wound/contamination class and NNIS score) rely on
subjective assessment. Moreover, it is delicate to compare
SSI rate to previous reports since deﬁnition of SSI was not
standardized among studies. However, the strength of the
present study was independent and prospective assessment
of SSI in all patients by the oﬃcial National surveillance com-
mittee. Thus, the results are likely to be representative for
everyday practice for physicians performing colonic surgery
within an ERAS program.
5. Conclusions
In conclusion, SSI remain a frequent problem after colonic
surgery. While ERAS compliance had no independent
impact, open approach, emergency surgery, smoking, and
bowel preparation were identiﬁed as independent risk factors
for SSI. Preoperative smoking cessation and favoring of min-
imally invasive surgery might contribute to better outcomes.
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